

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.52524973 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.52524973 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.23560937 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.23560937 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.48429999 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 5.07197605 |
| 7 | coenzyme catabolic process (GO:0009109) | 5.01021362 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.84924904 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.82241969 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.80910024 |
| 11 | cellular modified amino acid catabolic process (GO:0042219) | 4.77205961 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.63473659 |
| 13 | bile acid biosynthetic process (GO:0006699) | 4.62983906 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.55409530 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.55409530 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.55409530 |
| 17 | cysteine metabolic process (GO:0006534) | 4.35426178 |
| 18 | heme transport (GO:0015886) | 4.33579662 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 4.29105961 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.23121670 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.19052710 |
| 22 | protein carboxylation (GO:0018214) | 4.19052710 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 4.13751766 |
| 24 | urea cycle (GO:0000050) | 4.10942451 |
| 25 | urea metabolic process (GO:0019627) | 4.10942451 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.06893243 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.02551965 |
| 28 | bile acid metabolic process (GO:0008206) | 3.99563173 |
| 29 | fatty acid elongation (GO:0030497) | 3.98863868 |
| 30 | complement activation, alternative pathway (GO:0006957) | 3.85485656 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 3.84414585 |
| 32 | epoxygenase P450 pathway (GO:0019373) | 3.84301626 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 3.82754489 |
| 34 | regulation of protein activation cascade (GO:2000257) | 3.80415668 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.79217261 |
| 36 | cofactor catabolic process (GO:0051187) | 3.78552448 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.78332035 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 3.74578439 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 3.69797319 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.68929992 |
| 41 | lysine metabolic process (GO:0006553) | 3.68076512 |
| 42 | lysine catabolic process (GO:0006554) | 3.68076512 |
| 43 | glutamate metabolic process (GO:0006536) | 3.66650896 |
| 44 | cellular amino acid catabolic process (GO:0009063) | 3.66247686 |
| 45 | tyrosine metabolic process (GO:0006570) | 3.63482269 |
| 46 | acetyl-CoA metabolic process (GO:0006084) | 3.56883641 |
| 47 | negative regulation of sterol transport (GO:0032372) | 3.56605646 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 3.56605646 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.55894327 |
| 50 | regulation of complement activation (GO:0030449) | 3.55381720 |
| 51 | reverse cholesterol transport (GO:0043691) | 3.55121296 |
| 52 | ketone body metabolic process (GO:1902224) | 3.53529593 |
| 53 | protein retention in ER lumen (GO:0006621) | 3.53114418 |
| 54 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.52752765 |
| 55 | very long-chain fatty acid metabolic process (GO:0000038) | 3.51650541 |
| 56 | drug metabolic process (GO:0017144) | 3.49698847 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.43532012 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.43532012 |
| 59 | drug catabolic process (GO:0042737) | 3.42648088 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.40658813 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 3.40566761 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.40161795 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.39512425 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.39512425 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.39512425 |
| 66 | cholesterol efflux (GO:0033344) | 3.38470845 |
| 67 | ethanol oxidation (GO:0006069) | 3.36660554 |
| 68 | hormone catabolic process (GO:0042447) | 3.32829743 |
| 69 | axon ensheathment in central nervous system (GO:0032291) | 3.31369058 |
| 70 | central nervous system myelination (GO:0022010) | 3.31369058 |
| 71 | aspartate family amino acid catabolic process (GO:0009068) | 3.31348526 |
| 72 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.28719930 |
| 73 | amino-acid betaine metabolic process (GO:0006577) | 3.26575473 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.25799057 |
| 75 | phospholipid efflux (GO:0033700) | 3.25101673 |
| 76 | flavonoid metabolic process (GO:0009812) | 3.24195016 |
| 77 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.21633656 |
| 78 | iron coordination entity transport (GO:1901678) | 3.20350689 |
| 79 | COPI coating of Golgi vesicle (GO:0048205) | 3.19403655 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 3.19403655 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.17488844 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.17488844 |
| 83 | cellular glucuronidation (GO:0052695) | 3.17332374 |
| 84 | bile acid and bile salt transport (GO:0015721) | 3.14575364 |
| 85 | serine family amino acid metabolic process (GO:0009069) | 3.13961684 |
| 86 | biotin metabolic process (GO:0006768) | 3.13502511 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.11576889 |
| 88 | primary alcohol catabolic process (GO:0034310) | 3.11306787 |
| 89 | carboxylic acid catabolic process (GO:0046395) | 3.09851694 |
| 90 | organic acid catabolic process (GO:0016054) | 3.09851694 |
| 91 | fibrinolysis (GO:0042730) | 3.09741034 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.08909297 |
| 93 | arginine metabolic process (GO:0006525) | 3.08520361 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.07086497 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.05427567 |
| 96 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.05098183 |
| 97 | sterol homeostasis (GO:0055092) | 3.04962381 |
| 98 | cellular biogenic amine catabolic process (GO:0042402) | 3.04164230 |
| 99 | amine catabolic process (GO:0009310) | 3.04164230 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.02240512 |
| 101 | drug transmembrane transport (GO:0006855) | 2.98233052 |
| 102 | exogenous drug catabolic process (GO:0042738) | 2.98118611 |
| 103 | thioester biosynthetic process (GO:0035384) | 2.95372276 |
| 104 | acyl-CoA biosynthetic process (GO:0071616) | 2.95372276 |
| 105 | desmosome organization (GO:0002934) | 2.68872312 |
| 106 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.52070307 |
| 107 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.47931047 |
| 108 | axon extension involved in axon guidance (GO:0048846) | 2.47931047 |
| 109 | sodium ion export (GO:0071436) | 2.47471347 |
| 110 | gap junction assembly (GO:0016264) | 2.46781033 |
| 111 | skin morphogenesis (GO:0043589) | 2.46092900 |
| 112 | cell adhesion mediated by integrin (GO:0033627) | 2.44253663 |
| 113 | glutamate secretion (GO:0014047) | 2.43923865 |
| 114 | postsynaptic membrane organization (GO:0001941) | 2.37716556 |
| 115 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.36817009 |
| 116 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.31292879 |
| 117 | paraxial mesoderm development (GO:0048339) | 2.31018474 |
| 118 | vocalization behavior (GO:0071625) | 2.30170841 |
| 119 | cellular potassium ion homeostasis (GO:0030007) | 2.30091842 |
| 120 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.29251227 |
| 121 | axonal fasciculation (GO:0007413) | 2.28570709 |
| 122 | hemidesmosome assembly (GO:0031581) | 2.24210465 |
| 123 | neuron recognition (GO:0008038) | 2.23185209 |
| 124 | layer formation in cerebral cortex (GO:0021819) | 2.22704119 |
| 125 | nucleobase catabolic process (GO:0046113) | 2.21599850 |
| 126 | axon extension (GO:0048675) | 2.21569134 |
| 127 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.20659462 |
| 128 | cellular sodium ion homeostasis (GO:0006883) | 2.20408173 |
| 129 | proline biosynthetic process (GO:0006561) | 2.20132759 |
| 130 | 4-hydroxyproline metabolic process (GO:0019471) | 2.15959839 |
| 131 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.15224109 |
| 132 | peptidyl-proline hydroxylation (GO:0019511) | 2.14766944 |
| 133 | basement membrane organization (GO:0071711) | 2.14462910 |
| 134 | regulation of plasminogen activation (GO:0010755) | 2.13732109 |
| 135 | proline metabolic process (GO:0006560) | 2.13444659 |
| 136 | L-serine transport (GO:0015825) | 2.13431611 |
| 137 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.13382524 |
| 138 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.13351473 |
| 139 | doxorubicin metabolic process (GO:0044598) | 2.13305560 |
| 140 | daunorubicin metabolic process (GO:0044597) | 2.13305560 |
| 141 | polyketide metabolic process (GO:0030638) | 2.13305560 |
| 142 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.13057083 |
| 143 | cerebellar Purkinje cell layer development (GO:0021680) | 2.12736077 |
| 144 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.12337513 |
| 145 | apical protein localization (GO:0045176) | 2.10937660 |
| 146 | cholesterol biosynthetic process (GO:0006695) | 2.10503370 |
| 147 | negative regulation of catenin import into nucleus (GO:0035414) | 2.08824820 |
| 148 | neuronal ion channel clustering (GO:0045161) | 2.08093698 |
| 149 | phosphate ion transmembrane transport (GO:0035435) | 2.07185726 |
| 150 | semaphorin-plexin signaling pathway (GO:0071526) | 2.05088341 |
| 151 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.05064970 |
| 152 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.04966366 |
| 153 | cochlea morphogenesis (GO:0090103) | 2.04829714 |
| 154 | regulation of axon guidance (GO:1902667) | 2.04491183 |
| 155 | vesicle coating (GO:0006901) | 2.02357605 |
| 156 | ephrin receptor signaling pathway (GO:0048013) | 2.02115759 |
| 157 | intestinal cholesterol absorption (GO:0030299) | 1.99091362 |
| 158 | branching involved in salivary gland morphogenesis (GO:0060445) | 1.98184391 |
| 159 | COPII vesicle coating (GO:0048208) | 1.95612555 |
| 160 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 1.93673921 |
| 161 | response to hepatocyte growth factor (GO:0035728) | 1.93673921 |
| 162 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 1.93059921 |
| 163 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 1.92247267 |
| 164 | neuron projection extension (GO:1990138) | 1.92209019 |
| 165 | sterol biosynthetic process (GO:0016126) | 1.92084708 |
| 166 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 1.91536786 |
| 167 | notochord development (GO:0030903) | 1.91185758 |
| 168 | protein maturation by protein folding (GO:0022417) | 1.90883947 |
| 169 | glucose 6-phosphate metabolic process (GO:0051156) | 1.90325893 |
| 170 | purine nucleotide transport (GO:0015865) | 1.90192436 |
| 171 | phosphate ion transport (GO:0006817) | 1.89987056 |
| 172 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 1.89951667 |
| 173 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.89324579 |
| 174 | chondrocyte proliferation (GO:0035988) | 1.88981966 |
| 175 | regulation of cholesterol metabolic process (GO:0090181) | 1.88147364 |
| 176 | L-serine metabolic process (GO:0006563) | 1.86381255 |
| 177 | dendritic spine organization (GO:0097061) | 1.85518497 |
| 178 | aminoglycoside antibiotic metabolic process (GO:0030647) | 1.85215953 |
| 179 | regulation of establishment of planar polarity (GO:0090175) | 1.84866645 |
| 180 | negative regulation of lipase activity (GO:0060192) | 1.84359878 |
| 181 | cellular copper ion homeostasis (GO:0006878) | 1.84117111 |
| 182 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 1.83054350 |
| 183 | very-low-density lipoprotein particle assembly (GO:0034379) | 1.82261331 |
| 184 | cell communication involved in cardiac conduction (GO:0086065) | 1.79551630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.40012296 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.53550640 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.65756768 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47666434 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.73800171 |
| 6 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.47673740 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.38435863 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.21981988 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.98781619 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.88339440 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.77587666 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30970354 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.29768638 |
| 14 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.24681773 |
| 15 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.13770411 |
| 16 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.13770411 |
| 17 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.13770411 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.82053104 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.78889970 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78528732 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73487817 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67754256 |
| 23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.67622704 |
| 24 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.64930173 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64601369 |
| 26 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.62834236 |
| 27 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.55745104 |
| 28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51634323 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51482221 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.49410415 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.46665957 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43025700 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41966421 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34321295 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29762928 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29243633 |
| 37 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.28515245 |
| 38 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28092091 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28069322 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22510969 |
| 41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21999030 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20686945 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20606577 |
| 44 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.17010945 |
| 45 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16948984 |
| 46 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12361675 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11912869 |
| 48 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11267337 |
| 49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11227899 |
| 50 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10997910 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10579186 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09889815 |
| 53 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06776130 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05977801 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05377745 |
| 56 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.05049735 |
| 57 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04927030 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04296984 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04194496 |
| 60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04169828 |
| 61 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03833739 |
| 62 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03833739 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03610542 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.03049725 |
| 65 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03000002 |
| 66 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01997197 |
| 67 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01866739 |
| 68 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00748032 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00621640 |
| 70 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99239480 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99166738 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98114627 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97183039 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.96249540 |
| 75 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96009595 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95016159 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94352202 |
| 78 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.94307114 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93865336 |
| 80 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93653018 |
| 81 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93477461 |
| 82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92891191 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92078924 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91985048 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91966859 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91081275 |
| 87 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90918224 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90717382 |
| 89 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89206709 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87562474 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87337395 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86657677 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86657677 |
| 94 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86008170 |
| 95 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.85777706 |
| 96 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85424446 |
| 97 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.85321359 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85038024 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83951272 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82607635 |
| 101 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.82503370 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82328979 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82230943 |
| 104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.81409699 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.80870390 |
| 106 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80129210 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79828104 |
| 108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79090698 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78585915 |
| 110 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.77760262 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77584045 |
| 112 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.77233437 |
| 113 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76055640 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.75588626 |
| 115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.74866318 |
| 116 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74797126 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73601267 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73242169 |
| 119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.73225185 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.72786867 |
| 121 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.72459028 |
| 122 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.72291329 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71702250 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71090904 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.71066956 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71056290 |
| 127 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.70208855 |
| 128 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.69498665 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69224706 |
| 130 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68414376 |
| 131 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.67262421 |
| 132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.67133029 |
| 133 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66953656 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.66911277 |
| 135 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.66876697 |
| 136 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.66440135 |
| 137 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.66251414 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65891701 |
| 139 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.65799874 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65165964 |
| 141 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.65065917 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.64941948 |
| 143 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64376133 |
| 144 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.63805589 |
| 145 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.63757718 |
| 146 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63332586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.83348183 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.68855100 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.15813824 |
| 4 | MP0005365_abnormal_bile_salt | 4.97282697 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.51795794 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.50419759 |
| 7 | MP0009840_abnormal_foam_cell | 3.15800249 |
| 8 | MP0003252_abnormal_bile_duct | 3.15139504 |
| 9 | MP0003011_delayed_dark_adaptation | 2.87394672 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.81424396 |
| 11 | MP0005083_abnormal_biliary_tract | 2.62371111 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.59581265 |
| 13 | MP0004272_abnormal_basement_membrane | 2.58461345 |
| 14 | MP0005332_abnormal_amino_acid | 2.46044636 |
| 15 | MP0000566_synostosis | 2.43895222 |
| 16 | MP0002254_reproductive_system_inflammat | 2.30963854 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.22484310 |
| 18 | MP0003195_calcinosis | 2.20176514 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.10681215 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.07167960 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.01508489 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.92656098 |
| 23 | MP0000920_abnormal_myelination | 1.89437864 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.88849755 |
| 25 | MP0003329_amyloid_beta_deposits | 1.87180609 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.85444918 |
| 27 | MP0003122_maternal_imprinting | 1.83313441 |
| 28 | MP0000537_abnormal_urethra_morphology | 1.78778497 |
| 29 | MP0000609_abnormal_liver_physiology | 1.78600199 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.76244649 |
| 31 | MP0004264_abnormal_extraembryonic_tissu | 1.72223387 |
| 32 | MP0003690_abnormal_glial_cell | 1.70966975 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.63889116 |
| 34 | MP0005451_abnormal_body_composition | 1.60677346 |
| 35 | MP0004858_abnormal_nervous_system | 1.60142959 |
| 36 | MP0000604_amyloidosis | 1.58880862 |
| 37 | MP0001299_abnormal_eye_distance/ | 1.58529525 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.54939568 |
| 39 | MP0003880_abnormal_central_pattern | 1.54192456 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54131830 |
| 41 | MP0005275_abnormal_skin_tensile | 1.51695950 |
| 42 | MP0003941_abnormal_skin_development | 1.41751041 |
| 43 | MP0001529_abnormal_vocalization | 1.37796725 |
| 44 | MP0005423_abnormal_somatic_nervous | 1.33698365 |
| 45 | MP0003868_abnormal_feces_composition | 1.33047171 |
| 46 | MP0003123_paternal_imprinting | 1.29335942 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.28520548 |
| 48 | MP0000534_abnormal_ureter_morphology | 1.26042958 |
| 49 | MP0003942_abnormal_urinary_system | 1.24492567 |
| 50 | MP0009384_cardiac_valve_regurgitation | 1.24399591 |
| 51 | MP0004043_abnormal_pH_regulation | 1.23441982 |
| 52 | MP0005409_darkened_coat_color | 1.23179619 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.20845008 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.16074730 |
| 55 | MP0000049_abnormal_middle_ear | 1.15072398 |
| 56 | MP0006082_CNS_inflammation | 1.14626857 |
| 57 | MP0000462_abnormal_digestive_system | 1.14388015 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.12300781 |
| 59 | MP0000467_abnormal_esophagus_morphology | 1.11948475 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.09981694 |
| 61 | MP0003755_abnormal_palate_morphology | 1.04816494 |
| 62 | MP0002697_abnormal_eye_size | 1.04451616 |
| 63 | MP0003385_abnormal_body_wall | 1.04267900 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.02750899 |
| 65 | MP0002233_abnormal_nose_morphology | 1.01793572 |
| 66 | MP0004270_analgesia | 1.01040917 |
| 67 | MP0004381_abnormal_hair_follicle | 1.00574312 |
| 68 | MP0003937_abnormal_limbs/digits/tail_de | 0.99683389 |
| 69 | MP0003635_abnormal_synaptic_transmissio | 0.98304927 |
| 70 | MP0002796_impaired_skin_barrier | 0.97748198 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.96168235 |
| 72 | MP0004133_heterotaxia | 0.96167699 |
| 73 | MP0005508_abnormal_skeleton_morphology | 0.94258131 |
| 74 | MP0001177_atelectasis | 0.93140797 |
| 75 | MP0004885_abnormal_endolymph | 0.92929139 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.91271014 |
| 77 | MP0005187_abnormal_penis_morphology | 0.90509924 |
| 78 | MP0003861_abnormal_nervous_system | 0.90240838 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 0.90021618 |
| 80 | MP0002734_abnormal_mechanical_nocicepti | 0.89256302 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.88582573 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.87795898 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.86089579 |
| 84 | MP0002063_abnormal_learning/memory/cond | 0.85688567 |
| 85 | MP0002184_abnormal_innervation | 0.85434588 |
| 86 | MP0003115_abnormal_respiratory_system | 0.85120466 |
| 87 | MP0002938_white_spotting | 0.84961518 |
| 88 | MP0000598_abnormal_liver_morphology | 0.84917616 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.84714712 |
| 90 | MP0005248_abnormal_Harderian_gland | 0.84532133 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.83247747 |
| 92 | MP0003632_abnormal_nervous_system | 0.82474152 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.81670575 |
| 94 | MP0002116_abnormal_craniofacial_bone | 0.80802900 |
| 95 | MP0003283_abnormal_digestive_organ | 0.80487950 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.79238163 |
| 97 | MP0009250_abnormal_appendicular_skeleto | 0.78999318 |
| 98 | MP0003075_altered_response_to | 0.78627884 |
| 99 | MP0004233_abnormal_muscle_weight | 0.77806584 |
| 100 | MP0003890_abnormal_embryonic-extraembry | 0.77624004 |
| 101 | MP0002060_abnormal_skin_morphology | 0.77579275 |
| 102 | MP0002152_abnormal_brain_morphology | 0.77172733 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.77126027 |
| 104 | MP0003935_abnormal_craniofacial_develop | 0.76309104 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.76269220 |
| 106 | MP0002282_abnormal_trachea_morphology | 0.76084624 |
| 107 | MP0005266_abnormal_metabolism | 0.76025685 |
| 108 | MP0001958_emphysema | 0.76011755 |
| 109 | MP0003634_abnormal_glial_cell | 0.75610183 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.75251452 |
| 111 | MP0009053_abnormal_anal_canal | 0.75233278 |
| 112 | MP0002572_abnormal_emotion/affect_behav | 0.74818646 |
| 113 | MP0009672_abnormal_birth_weight | 0.74564911 |
| 114 | MP0005023_abnormal_wound_healing | 0.73161400 |
| 115 | MP0002557_abnormal_social/conspecific_i | 0.72807735 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.72002215 |
| 117 | MP0005501_abnormal_skin_physiology | 0.71892156 |
| 118 | MP0001984_abnormal_olfaction | 0.71336294 |
| 119 | MP0002882_abnormal_neuron_morphology | 0.70816304 |
| 120 | MP0001286_abnormal_eye_development | 0.68737066 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.68605732 |
| 122 | MP0003119_abnormal_digestive_system | 0.68288609 |
| 123 | MP0005499_abnormal_olfactory_system | 0.68224385 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.68224385 |
| 125 | MP0008874_decreased_physiological_sensi | 0.66969466 |
| 126 | MP0000647_abnormal_sebaceous_gland | 0.66313499 |
| 127 | MP0005636_abnormal_mineral_homeostasis | 0.65105505 |
| 128 | MP0004142_abnormal_muscle_tone | 0.65015624 |
| 129 | MP0005376_homeostasis/metabolism_phenot | 0.64745311 |
| 130 | MP0003186_abnormal_redox_activity | 0.64651695 |
| 131 | MP0001849_ear_inflammation | 0.63377762 |
| 132 | MP0000579_abnormal_nail_morphology | 0.62413290 |
| 133 | MP0002229_neurodegeneration | 0.59569269 |
| 134 | MP0009764_decreased_sensitivity_to | 0.58702332 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.58293323 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.58288258 |
| 137 | MP0004130_abnormal_muscle_cell | 0.58030631 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.56814394 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.56443166 |
| 140 | MP0009763_increased_sensitivity_to | 0.56018945 |
| 141 | MP0009642_abnormal_blood_homeostasis | 0.55242302 |
| 142 | MP0003938_abnormal_ear_development | 0.55050212 |
| 143 | MP0001486_abnormal_startle_reflex | 0.54322608 |
| 144 | MP0005647_abnormal_sex_gland | 0.54046759 |
| 145 | MP0000778_abnormal_nervous_system | 0.53484656 |
| 146 | MP0000383_abnormal_hair_follicle | 0.52598763 |
| 147 | MP0000762_abnormal_tongue_morphology | 0.51259074 |
| 148 | MP0002092_abnormal_eye_morphology | 0.50469722 |
| 149 | MP0005058_abnormal_lysosome_morphology | 0.50231164 |
| 150 | MP0003172_abnormal_lysosome_physiology | 0.49539006 |
| 151 | MP0006036_abnormal_mitochondrial_physio | 0.48992527 |
| 152 | MP0002098_abnormal_vibrissa_morphology | 0.48332515 |
| 153 | MP0000377_abnormal_hair_follicle | 0.46893206 |
| 154 | MP0005448_abnormal_energy_balance | 0.46890341 |
| 155 | MP0002090_abnormal_vision | 0.46570724 |
| 156 | MP0004883_abnormal_blood_vessel | 0.46269087 |
| 157 | MP0002971_abnormal_brown_adipose | 0.46019123 |
| 158 | MP0003183_abnormal_peptide_metabolism | 0.45933397 |
| 159 | MP0002269_muscular_atrophy | 0.45626463 |
| 160 | MP0001756_abnormal_urination | 0.45419260 |
| 161 | MP0002078_abnormal_glucose_homeostasis | 0.45370920 |
| 162 | MP0003453_abnormal_keratinocyte_physiol | 0.44247430 |
| 163 | MP0004859_abnormal_synaptic_plasticity | 0.44153668 |
| 164 | MP0005535_abnormal_body_temperature | 0.43592002 |
| 165 | MP0005666_abnormal_adipose_tissue | 0.43256486 |
| 166 | MP0003633_abnormal_nervous_system | 0.43255856 |
| 167 | MP0000955_abnormal_spinal_cord | 0.43114044 |
| 168 | MP0003631_nervous_system_phenotype | 0.42836405 |
| 169 | MP0002064_seizures | 0.42246888 |
| 170 | MP0001764_abnormal_homeostasis | 0.41778660 |
| 171 | MP0001348_abnormal_lacrimal_gland | 0.41594175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.97855598 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.96777517 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.90577252 |
| 4 | Xanthomatosis (HP:0000991) | 5.20973025 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.77523531 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.31132486 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.31121611 |
| 8 | Hypochromic microcytic anemia (HP:0004840) | 4.30751146 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.30364290 |
| 10 | Complement deficiency (HP:0004431) | 3.99039605 |
| 11 | Hyperammonemia (HP:0001987) | 3.75478274 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 3.69788212 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.69788212 |
| 14 | Ketosis (HP:0001946) | 3.64679352 |
| 15 | Epidermoid cyst (HP:0200040) | 3.60055019 |
| 16 | Hyperglycinuria (HP:0003108) | 3.49203986 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.38460629 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.36420537 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.36012502 |
| 20 | Hepatoblastoma (HP:0002884) | 3.35114230 |
| 21 | Hyperglycinemia (HP:0002154) | 3.33256026 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.28000064 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.26337051 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22463921 |
| 25 | Joint hemorrhage (HP:0005261) | 3.22310146 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.10602525 |
| 27 | Fat malabsorption (HP:0002630) | 3.07243383 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.06215670 |
| 29 | Skin nodule (HP:0200036) | 3.03866937 |
| 30 | Protrusio acetabuli (HP:0003179) | 3.03149652 |
| 31 | Gout (HP:0001997) | 3.01507096 |
| 32 | Abnormality of the corticospinal tract (HP:0002492) | 3.00767263 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 2.99371266 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 2.91818479 |
| 35 | Malnutrition (HP:0004395) | 2.91762731 |
| 36 | Abnormality of complement system (HP:0005339) | 2.87971540 |
| 37 | Delayed CNS myelination (HP:0002188) | 2.85984048 |
| 38 | Hyperventilation (HP:0002883) | 2.81393327 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.79864049 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79598687 |
| 41 | Abnormality of the lower motor neuron (HP:0002366) | 2.79435268 |
| 42 | Sensory axonal neuropathy (HP:0003390) | 2.76057431 |
| 43 | Ketoacidosis (HP:0001993) | 2.71906400 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.71013180 |
| 45 | Spastic tetraparesis (HP:0001285) | 2.67778519 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.66825591 |
| 47 | Amyloidosis (HP:0011034) | 2.63939750 |
| 48 | Shallow orbits (HP:0000586) | 2.58671070 |
| 49 | Abnormality of dentin (HP:0010299) | 2.52355839 |
| 50 | Bilateral microphthalmos (HP:0007633) | 2.51985497 |
| 51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.49424455 |
| 52 | Irritability (HP:0000737) | 2.45394180 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.42789524 |
| 54 | Metabolic acidosis (HP:0001942) | 2.42724671 |
| 55 | Abnormal cartilage morphology (HP:0002763) | 2.41452670 |
| 56 | Vascular calcification (HP:0004934) | 2.39363060 |
| 57 | Abnormality of glycolysis (HP:0004366) | 2.36041299 |
| 58 | Increased serum pyruvate (HP:0003542) | 2.36041299 |
| 59 | Coronal craniosynostosis (HP:0004440) | 2.35697186 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.35317918 |
| 61 | Cholecystitis (HP:0001082) | 2.35317918 |
| 62 | Rickets (HP:0002748) | 2.34373722 |
| 63 | Vascular tortuosity (HP:0004948) | 2.34284481 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.32075529 |
| 65 | Arterial tortuosity (HP:0005116) | 2.31998842 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.31566557 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29900871 |
| 68 | Steatorrhea (HP:0002570) | 2.28831072 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.28704121 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.26391506 |
| 71 | Cholelithiasis (HP:0001081) | 2.24825009 |
| 72 | Status epilepticus (HP:0002133) | 2.24285591 |
| 73 | Atrophic scars (HP:0001075) | 2.16380654 |
| 74 | Axonal loss (HP:0003447) | 2.15730864 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.15626827 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.14555125 |
| 77 | Distal upper limb amyotrophy (HP:0007149) | 2.12672814 |
| 78 | Upper limb amyotrophy (HP:0009129) | 2.12672814 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 2.11496699 |
| 80 | Hand muscle atrophy (HP:0009130) | 2.11255472 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.11100340 |
| 82 | Peritonitis (HP:0002586) | 2.09576005 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.07708167 |
| 84 | Aplasia involving bones of the extremities (HP:0009825) | 2.06098923 |
| 85 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.06098923 |
| 86 | Aplasia of the phalanges of the hand (HP:0009802) | 2.06098923 |
| 87 | Hypoglycemic coma (HP:0001325) | 2.05921187 |
| 88 | Tetraplegia (HP:0002445) | 2.05310865 |
| 89 | Bladder diverticulum (HP:0000015) | 2.04774263 |
| 90 | Intention tremor (HP:0002080) | 2.03493627 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 2.02838348 |
| 92 | Myocardial infarction (HP:0001658) | 2.02664680 |
| 93 | Bronchomalacia (HP:0002780) | 2.02292574 |
| 94 | Neonatal short-limb short stature (HP:0008921) | 2.02259308 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 2.01013033 |
| 96 | Spastic paraparesis (HP:0002313) | 2.00608473 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00350428 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.00350428 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99095081 |
| 100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98130536 |
| 101 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98130536 |
| 102 | Myokymia (HP:0002411) | 1.97734556 |
| 103 | Pseudobulbar signs (HP:0002200) | 1.96434307 |
| 104 | Action tremor (HP:0002345) | 1.95981034 |
| 105 | Split foot (HP:0001839) | 1.93099847 |
| 106 | Abnormality of serum amino acid levels (HP:0003112) | 1.93087190 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 1.92612260 |
| 108 | Follicular hyperkeratosis (HP:0007502) | 1.91347689 |
| 109 | Turricephaly (HP:0000262) | 1.90291908 |
| 110 | Cervical subluxation (HP:0003308) | 1.89955419 |
| 111 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.88793055 |
| 112 | Vomiting (HP:0002013) | 1.88508437 |
| 113 | Multiple enchondromatosis (HP:0005701) | 1.87514162 |
| 114 | Broad metatarsal (HP:0001783) | 1.87349261 |
| 115 | Abnormality of carpal bone ossification (HP:0006257) | 1.87087301 |
| 116 | Supranuclear gaze palsy (HP:0000605) | 1.83215770 |
| 117 | Pterygium (HP:0001059) | 1.83161148 |
| 118 | Back pain (HP:0003418) | 1.80870199 |
| 119 | Upper motor neuron abnormality (HP:0002127) | 1.80269391 |
| 120 | Peripheral demyelination (HP:0011096) | 1.79887945 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78466044 |
| 122 | Microglossia (HP:0000171) | 1.77629144 |
| 123 | Hammertoe (HP:0001765) | 1.77251011 |
| 124 | Lethargy (HP:0001254) | 1.76866944 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 1.76523522 |
| 126 | Mitral stenosis (HP:0001718) | 1.75954464 |
| 127 | Elevated alkaline phosphatase (HP:0003155) | 1.75277416 |
| 128 | Abnormality of vitamin metabolism (HP:0100508) | 1.75136477 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 1.74215078 |
| 130 | Ankle contracture (HP:0006466) | 1.74167664 |
| 131 | Insomnia (HP:0100785) | 1.70874268 |
| 132 | Renal duplication (HP:0000075) | 1.69112909 |
| 133 | Abnormality of pain sensation (HP:0010832) | 1.68385294 |
| 134 | Impaired pain sensation (HP:0007328) | 1.68385294 |
| 135 | Cortical dysplasia (HP:0002539) | 1.68161061 |
| 136 | Ulnar bowing (HP:0003031) | 1.66543775 |
| 137 | Insidious onset (HP:0003587) | 1.65747459 |
| 138 | Termporal pattern (HP:0011008) | 1.65747459 |
| 139 | Soft skin (HP:0000977) | 1.64554983 |
| 140 | Arnold-Chiari malformation (HP:0002308) | 1.64446606 |
| 141 | Fragile skin (HP:0001030) | 1.63170240 |
| 142 | Overriding aorta (HP:0002623) | 1.62268900 |
| 143 | Aortic dissection (HP:0002647) | 1.62128829 |
| 144 | Bifid scrotum (HP:0000048) | 1.61046799 |
| 145 | Short nail (HP:0001799) | 1.60584634 |
| 146 | Wormian bones (HP:0002645) | 1.59862823 |
| 147 | Infantile muscular hypotonia (HP:0008947) | 1.59790337 |
| 148 | Spinal rigidity (HP:0003306) | 1.59493491 |
| 149 | Hypoplastic pelvis (HP:0008839) | 1.58782393 |
| 150 | Premature skin wrinkling (HP:0100678) | 1.58083536 |
| 151 | Abnormal ossification of hand bones (HP:0005921) | 1.56347653 |
| 152 | Hyperacusis (HP:0010780) | 1.53691583 |
| 153 | Choanal stenosis (HP:0000452) | 1.53327900 |
| 154 | Abnormal delivery (HP:0001787) | 1.53046010 |
| 155 | Partial duplication of thumb phalanx (HP:0009944) | 1.51603570 |
| 156 | Abnormal hand bone ossification (HP:0010660) | 1.50364601 |
| 157 | Torticollis (HP:0000473) | 1.49887825 |
| 158 | Hyperextensible skin (HP:0000974) | 1.49116242 |
| 159 | Flat acetabular roof (HP:0003180) | 1.46729116 |
| 160 | Partial duplication of the phalanx of hand (HP:0009999) | 1.44572347 |
| 161 | Abnormality of molar (HP:0011077) | 1.43381285 |
| 162 | Abnormality of molar morphology (HP:0011070) | 1.43381285 |
| 163 | Alacrima (HP:0000522) | 1.42847488 |
| 164 | Hypoventilation (HP:0002791) | 1.41618286 |
| 165 | Mixed hearing impairment (HP:0000410) | 1.40204495 |
| 166 | Abnormality of the dental root (HP:0006486) | 1.39679287 |
| 167 | Taurodontia (HP:0000679) | 1.39679287 |
| 168 | Abnormality of permanent molar morphology (HP:0011071) | 1.39679287 |
| 169 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.38313502 |
| 170 | Vertebral compression fractures (HP:0002953) | 1.38190013 |
| 171 | Mitral regurgitation (HP:0001653) | 1.37714179 |
| 172 | Generalized hypotonia (HP:0001290) | 1.37145098 |
| 173 | Nuclear cataract (HP:0100018) | 1.36263718 |
| 174 | Advanced eruption of teeth (HP:0006288) | 1.35730917 |
| 175 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.34070416 |
| 176 | Myelomeningocele (HP:0002475) | 1.33814678 |
| 177 | Broad alveolar ridges (HP:0000187) | 1.33627450 |
| 178 | Fragile nails (HP:0001808) | 1.31961988 |
| 179 | Polyphagia (HP:0002591) | 1.29364837 |
| 180 | Congenital glaucoma (HP:0001087) | 1.28769383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.95200164 |
| 2 | CDK12 | 3.97699799 |
| 3 | EPHA2 | 2.97458104 |
| 4 | CASK | 2.56510681 |
| 5 | STK39 | 2.53533465 |
| 6 | EPHB1 | 2.48578227 |
| 7 | GRK5 | 2.47414319 |
| 8 | OXSR1 | 2.39751905 |
| 9 | BCKDK | 2.34339119 |
| 10 | TYRO3 | 2.28972999 |
| 11 | SIK1 | 2.09714427 |
| 12 | GRK6 | 2.09510172 |
| 13 | WNK1 | 1.95637916 |
| 14 | ICK | 1.90894522 |
| 15 | CSF1R | 1.89959989 |
| 16 | LMTK2 | 1.88121812 |
| 17 | TESK1 | 1.86778994 |
| 18 | PRKD3 | 1.84984782 |
| 19 | MAP3K9 | 1.84901185 |
| 20 | NTRK1 | 1.81726422 |
| 21 | FGFR2 | 1.72128147 |
| 22 | PRPF4B | 1.69545484 |
| 23 | MAP2K4 | 1.67005024 |
| 24 | FGFR4 | 1.62258503 |
| 25 | MAPK7 | 1.58301571 |
| 26 | MET | 1.53545662 |
| 27 | TGFBR2 | 1.53114109 |
| 28 | GRK1 | 1.49883919 |
| 29 | PBK | 1.39270096 |
| 30 | MARK1 | 1.33861232 |
| 31 | WNK4 | 1.32274624 |
| 32 | CDK19 | 1.28919771 |
| 33 | BCR | 1.26802756 |
| 34 | MATK | 1.24000139 |
| 35 | ERBB4 | 1.23326146 |
| 36 | PKN1 | 1.23107900 |
| 37 | MARK2 | 1.22070560 |
| 38 | MINK1 | 1.19369075 |
| 39 | PAK6 | 1.18685305 |
| 40 | PAK3 | 1.10845483 |
| 41 | MAP2K7 | 1.10101803 |
| 42 | ADRBK2 | 1.09741262 |
| 43 | MAP3K7 | 1.09584880 |
| 44 | EPHA4 | 1.05819042 |
| 45 | TNIK | 1.04810426 |
| 46 | DMPK | 0.99707130 |
| 47 | CAMK1D | 0.96957767 |
| 48 | GRK7 | 0.95477091 |
| 49 | MAPK12 | 0.94563566 |
| 50 | PNCK | 0.93163938 |
| 51 | NTRK3 | 0.92593561 |
| 52 | FER | 0.92255687 |
| 53 | PTK2 | 0.91840176 |
| 54 | CAMK4 | 0.91469614 |
| 55 | PAK4 | 0.90844558 |
| 56 | UHMK1 | 0.87787198 |
| 57 | BMX | 0.87243224 |
| 58 | CAMK1G | 0.83782471 |
| 59 | MOS | 0.83719378 |
| 60 | FGFR1 | 0.83126718 |
| 61 | CAMK2B | 0.82964564 |
| 62 | CSNK1A1L | 0.81241818 |
| 63 | KSR2 | 0.81059392 |
| 64 | ERBB2 | 0.79685631 |
| 65 | PLK2 | 0.78305169 |
| 66 | DDR2 | 0.76919778 |
| 67 | CSK | 0.75933913 |
| 68 | DAPK2 | 0.75690808 |
| 69 | CSNK1G3 | 0.75272925 |
| 70 | PRKG2 | 0.75221318 |
| 71 | FGR | 0.74548595 |
| 72 | PAK2 | 0.73264859 |
| 73 | DYRK2 | 0.71608053 |
| 74 | TSSK6 | 0.71540839 |
| 75 | TRIB3 | 0.71049531 |
| 76 | CSNK1G2 | 0.70647129 |
| 77 | STK10 | 0.70578444 |
| 78 | PIK3CA | 0.70166150 |
| 79 | NEK1 | 0.69593685 |
| 80 | MST1R | 0.68702592 |
| 81 | CAMK2D | 0.68429290 |
| 82 | ARAF | 0.68307079 |
| 83 | LATS1 | 0.68258382 |
| 84 | MAP3K4 | 0.68047125 |
| 85 | PRKCG | 0.66454707 |
| 86 | PHKG1 | 0.65090114 |
| 87 | PHKG2 | 0.65090114 |
| 88 | RIPK1 | 0.63326548 |
| 89 | BRSK1 | 0.62884112 |
| 90 | CSNK1G1 | 0.62160239 |
| 91 | MAP3K10 | 0.61630669 |
| 92 | GSK3A | 0.60445031 |
| 93 | PDK2 | 0.60067116 |
| 94 | ILK | 0.59683705 |
| 95 | EPHB2 | 0.59325512 |
| 96 | LATS2 | 0.58356833 |
| 97 | PDPK1 | 0.58272806 |
| 98 | STK38 | 0.56400059 |
| 99 | PRKD1 | 0.55933063 |
| 100 | MTOR | 0.55344745 |
| 101 | EIF2AK1 | 0.55028023 |
| 102 | PRKCI | 0.54789230 |
| 103 | EPHA3 | 0.54263132 |
| 104 | PDGFRB | 0.54206686 |
| 105 | WNK3 | 0.53994967 |
| 106 | PIM2 | 0.53391693 |
| 107 | MAPKAPK5 | 0.53130217 |
| 108 | ABL2 | 0.53089403 |
| 109 | PRKACG | 0.52235963 |
| 110 | TRIM28 | 0.52070382 |
| 111 | PRKCE | 0.51176370 |
| 112 | CDK15 | 0.50894323 |
| 113 | TESK2 | 0.50629065 |
| 114 | CDK5 | 0.50132262 |
| 115 | CDK18 | 0.49363815 |
| 116 | CSNK1E | 0.49100957 |
| 117 | IRAK3 | 0.48877191 |
| 118 | CDK14 | 0.48348465 |
| 119 | CAMK2G | 0.48254547 |
| 120 | PRKCZ | 0.47515516 |
| 121 | MAPK4 | 0.47462591 |
| 122 | FYN | 0.46830138 |
| 123 | AKT3 | 0.46715718 |
| 124 | RET | 0.46509256 |
| 125 | PDK1 | 0.45417228 |
| 126 | FGFR3 | 0.45405981 |
| 127 | SGK494 | 0.45329300 |
| 128 | SGK223 | 0.45329300 |
| 129 | PRKCQ | 0.44126167 |
| 130 | LIMK1 | 0.43705998 |
| 131 | STK38L | 0.43478181 |
| 132 | MAP2K6 | 0.43240337 |
| 133 | NTRK2 | 0.43157465 |
| 134 | ROCK2 | 0.42720147 |
| 135 | PDGFRA | 0.42612627 |
| 136 | PTK6 | 0.42530957 |
| 137 | CDK11A | 0.41101880 |
| 138 | DYRK1B | 0.40494182 |
| 139 | JAK2 | 0.40209120 |
| 140 | MAP3K12 | 0.40056388 |
| 141 | PRKAA2 | 0.39554110 |
| 142 | PKN2 | 0.38789477 |
| 143 | EGFR | 0.38562552 |
| 144 | DYRK1A | 0.38340536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.71163382 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52060236 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.97507898 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85036020 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69824173 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63385698 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.52354928 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49131470 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43059157 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41973899 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32783359 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32269938 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.25331835 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14528876 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10643827 |
| 16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.06650643 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02587730 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92234963 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87426130 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86960958 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84154309 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82368685 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81945016 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.78356665 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75855345 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74266023 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65515212 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.65213908 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60943830 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48472891 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45646033 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40697792 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40337842 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38301522 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36464313 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29810138 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29559983 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22104151 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19098336 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17325588 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12130625 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11916660 |
| 43 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.10139778 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07544599 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.03843434 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02319871 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01999549 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01775411 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.01431168 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01066059 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00921763 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00296916 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 1.00217506 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99856871 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98938908 |
| 56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95837790 |
| 57 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95294839 |
| 58 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.94913557 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92452448 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92174717 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.89056676 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88325938 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87581634 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85104608 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80482113 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80277774 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79182318 |
| 68 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77361939 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76193722 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73477339 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73350457 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.73150867 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72994901 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70927303 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67565689 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66349528 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66191504 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.66159624 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64876674 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63843472 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63385311 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62722138 |
| 83 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61245263 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.59986930 |
| 85 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59788357 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.59710790 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.59438830 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59254497 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54837030 |
| 90 | Protein export_Homo sapiens_hsa03060 | 0.53078748 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52931699 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52774914 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52355320 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.51579029 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.51151358 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49726947 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47461860 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44454195 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.44314052 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40035104 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38014049 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36732423 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35939347 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35746613 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35719233 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31785901 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.28394684 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26316566 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25012659 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23083921 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.18082874 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17198856 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.15202679 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.15196535 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11027034 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.09535146 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07143308 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.06459155 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.06387921 |
| 120 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06165854 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.05352343 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03986384 |
| 123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03515149 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.02723094 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.01318774 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.00996892 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.00983248 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0369993 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0083798 |
| 130 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0034106 |

